Journal article
Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture
Abstract
Minimizing post-fracture bone loss is an important aspect of recovery from hip fracture, and determination of factors that affect bone mineral density (BMD) response to treatment after hip fracture may assist in the development of targeted therapeutic interventions. A post hoc analysis of the HORIZON Recurrent Fracture Trial was done to determine the effect of zoledronic acid (ZOL) on total hip (TH) and femoral neck (FN) BMD in subgroups with …
Authors
Magaziner JS; Orwig DL; Lyles KW; Nordsletten L; Boonen S; Adachi JD; Recknor C; Colón‐Emeric CS; Mesenbrink P; Bucci‐Rechtweg C
Journal
Journal of Bone and Mineral Research, Vol. 29, No. 12, pp. 2545–2551
Publisher
Oxford University Press (OUP)
Publication Date
December 1, 2014
DOI
10.1002/jbmr.2283
ISSN
0884-0431